Carrier Route Information System (CRIS)

Type: Public
On the web: http://www.curis.com
Employees: 34
Employee growth: (19.0%)

Curis's cancer patients and Sega's gamers might one day have an unlikely hero in common: Sonic the Hedgehog. Drug development firm Curis is studying hedgehog signaling pathways (including the sonic hedgehog pathway, named after the Sega mascot) to find treatments for cancer, neurological disease, and cardiovascular conditions. Such signaling pathways regulate tissue growth and repair, and the company is looking for ways to either stimulate them or slow them down as a means of treating disease. Curis is collaborating with Genentech to develop cancer drugs using hedgehog pathways. The company also has internal development programs for cancer treatments using other signaling pathways.

Key numbers for fiscal year ending December, 2008:
Sales: $8.4M
One year growth: (48.9%)
Net income: ($12.1)M

Officers:
Chairman: James R. McNab Jr.
President, CEO, and Director: Daniel R. (Dan) Passeri
CFO and COO: Michael P. (Mike) Gray

Competitors:
Celgene Signal Research
Eli Lilly
Semafore Pharmaceuticals

File maintained by the U.S. Postal Service that lists all of the approximately 570,000 carrier routes by street name or ranges of street numbers. It is used by large-volume mailers to append the carrier route to the name and address records on their mailing lists so that mailings can be presorted accordingly, thereby earning a postage discount. See also address coding guide; carrier route coding; carrier route presort; carrier route qualified.